ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global COPD and Asthma Drug Devices Market Research Report 2025
Published Date: August 2025
|
Report Code: QYRE-Auto-13K9733
Home | Market Reports | Health| Health Conditions| Respiratory Conditions
Global COPD and Asthma Drug Devices Market Insights Forecast to 2028
BUY CHAPTERS

Global COPD and Asthma Drug Devices Market Research Report 2025

Code: QYRE-Auto-13K9733
Report
August 2025
Pages:85
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Novartis International AG
Merck
Astrazeneca plc
GlaxoSmithKline PLC
3M Healthcare
GF Health Products, Inc
Sunovion Pharmaceuticals Inc
Smith Medicals, Inc.
Baxter International
Koninklijke Philips N V

COPD and Asthma Drug Devices Market Size

The global market for COPD and Asthma Drug Devices was valued at US$ 266 million in the year 2024 and is projected to reach a revised size of US$ 415 million by 2031, growing at a CAGR of 6.6% during the forecast period.

COPD and Asthma Drug Devices Market

COPD and Asthma Drug Devices Market

COPD and Asthma Drug Devices or dry powder inhaler (DPI) is a device that delivers medication to the lungs in the form of a dry powder. DPIs are commonly used to treat respiratory diseases such as asthma, bronchitis, emphysema and COPD although DPIs (such as inhalable insulin Afrezza) have also been used in the treatment of diabetes mellitus.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for COPD and Asthma Drug Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding COPD and Asthma Drug Devices.
The COPD and Asthma Drug Devices market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global COPD and Asthma Drug Devices market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the COPD and Asthma Drug Devices manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of COPD and Asthma Drug Devices Market Report

Report Metric Details
Report Name COPD and Asthma Drug Devices Market
Accounted market size in year US$ 266 million
Forecasted market size in 2031 US$ 415 million
CAGR 6.6%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • COPD & Asthma Inhaler
  • COPD & Asthma Nebulizer
Segment by Application
  • Hospitals
  • Clinics
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Novartis International AG, Merck, AstraZeneca, GlaxoSmithKline, 3M Healthcare, GF Health Products, Inc, Sunovion Pharmaceuticals Inc., Smith Medicals, Inc., Baxter International, Koninklijke Philips N.V.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of COPD and Asthma Drug Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of COPD and Asthma Drug Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is COPD and Asthma Drug Devices Market growing?

Ans: The COPD and Asthma Drug Devices Market witnessing a CAGR of 6.6% during the forecast period 2025-2031.

What is the COPD and Asthma Drug Devices Market size in 2031?

Ans: The COPD and Asthma Drug Devices Market size in 2031 will be US$ 415 million.

Who are the main players in the COPD and Asthma Drug Devices Market report?

Ans: The main players in the COPD and Asthma Drug Devices Market are Novartis International AG, Merck, AstraZeneca, GlaxoSmithKline, 3M Healthcare, GF Health Products, Inc, Sunovion Pharmaceuticals Inc., Smith Medicals, Inc., Baxter International, Koninklijke Philips N.V.

What are the Application segmentation covered in the COPD and Asthma Drug Devices Market report?

Ans: The Applications covered in the COPD and Asthma Drug Devices Market report are Hospitals, Clinics, Others

What are the Type segmentation covered in the COPD and Asthma Drug Devices Market report?

Ans: The Types covered in the COPD and Asthma Drug Devices Market report are COPD & Asthma Inhaler, COPD & Asthma Nebulizer

Recommended Reports

Asthma Therapeutics

COPD Drug Markets

Inhalation Device Markets

1 COPD and Asthma Drug Devices Market Overview
1.1 Product Definition
1.2 COPD and Asthma Drug Devices by Type
1.2.1 Global COPD and Asthma Drug Devices Market Value Comparison by Type (2024 VS 2031)
1.2.2 COPD & Asthma Inhaler
1.2.3 COPD & Asthma Nebulizer
1.3 COPD and Asthma Drug Devices by Application
1.3.1 Global COPD and Asthma Drug Devices Market Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global COPD and Asthma Drug Devices Market Size Estimates and Forecasts
1.4.1 Global COPD and Asthma Drug Devices Revenue 2020-2031
1.4.2 Global COPD and Asthma Drug Devices Sales 2020-2031
1.4.3 Global COPD and Asthma Drug Devices Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 COPD and Asthma Drug Devices Market Competition by Manufacturers
2.1 Global COPD and Asthma Drug Devices Sales Market Share by Manufacturers (2020-2025)
2.2 Global COPD and Asthma Drug Devices Revenue Market Share by Manufacturers (2020-2025)
2.3 Global COPD and Asthma Drug Devices Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of COPD and Asthma Drug Devices, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of COPD and Asthma Drug Devices, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of COPD and Asthma Drug Devices, Product Type & Application
2.7 Global Key Manufacturers of COPD and Asthma Drug Devices, Date of Enter into This Industry
2.8 Global COPD and Asthma Drug Devices Market Competitive Situation and Trends
2.8.1 Global COPD and Asthma Drug Devices Market Concentration Rate
2.8.2 The Global 5 and 10 Largest COPD and Asthma Drug Devices Players Market Share by Revenue
2.8.3 Global COPD and Asthma Drug Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global COPD and Asthma Drug Devices Market Scenario by Region
3.1 Global COPD and Asthma Drug Devices Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global COPD and Asthma Drug Devices Sales by Region: 2020-2031
3.2.1 Global COPD and Asthma Drug Devices Sales by Region: 2020-2025
3.2.2 Global COPD and Asthma Drug Devices Sales by Region: 2026-2031
3.3 Global COPD and Asthma Drug Devices Revenue by Region: 2020-2031
3.3.1 Global COPD and Asthma Drug Devices Revenue by Region: 2020-2025
3.3.2 Global COPD and Asthma Drug Devices Revenue by Region: 2026-2031
3.4 North America COPD and Asthma Drug Devices Market Facts & Figures by Country
3.4.1 North America COPD and Asthma Drug Devices Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America COPD and Asthma Drug Devices Sales by Country (2020-2031)
3.4.3 North America COPD and Asthma Drug Devices Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe COPD and Asthma Drug Devices Market Facts & Figures by Country
3.5.1 Europe COPD and Asthma Drug Devices Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe COPD and Asthma Drug Devices Sales by Country (2020-2031)
3.5.3 Europe COPD and Asthma Drug Devices Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific COPD and Asthma Drug Devices Market Facts & Figures by Region
3.6.1 Asia Pacific COPD and Asthma Drug Devices Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific COPD and Asthma Drug Devices Sales by Region (2020-2031)
3.6.3 Asia Pacific COPD and Asthma Drug Devices Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America COPD and Asthma Drug Devices Market Facts & Figures by Country
3.7.1 Latin America COPD and Asthma Drug Devices Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America COPD and Asthma Drug Devices Sales by Country (2020-2031)
3.7.3 Latin America COPD and Asthma Drug Devices Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa COPD and Asthma Drug Devices Market Facts & Figures by Country
3.8.1 Middle East and Africa COPD and Asthma Drug Devices Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa COPD and Asthma Drug Devices Sales by Country (2020-2031)
3.8.3 Middle East and Africa COPD and Asthma Drug Devices Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global COPD and Asthma Drug Devices Sales by Type (2020-2031)
4.1.1 Global COPD and Asthma Drug Devices Sales by Type (2020-2025)
4.1.2 Global COPD and Asthma Drug Devices Sales by Type (2026-2031)
4.1.3 Global COPD and Asthma Drug Devices Sales Market Share by Type (2020-2031)
4.2 Global COPD and Asthma Drug Devices Revenue by Type (2020-2031)
4.2.1 Global COPD and Asthma Drug Devices Revenue by Type (2020-2025)
4.2.2 Global COPD and Asthma Drug Devices Revenue by Type (2026-2031)
4.2.3 Global COPD and Asthma Drug Devices Revenue Market Share by Type (2020-2031)
4.3 Global COPD and Asthma Drug Devices Price by Type (2020-2031)
5 Segment by Application
5.1 Global COPD and Asthma Drug Devices Sales by Application (2020-2031)
5.1.1 Global COPD and Asthma Drug Devices Sales by Application (2020-2025)
5.1.2 Global COPD and Asthma Drug Devices Sales by Application (2026-2031)
5.1.3 Global COPD and Asthma Drug Devices Sales Market Share by Application (2020-2031)
5.2 Global COPD and Asthma Drug Devices Revenue by Application (2020-2031)
5.2.1 Global COPD and Asthma Drug Devices Revenue by Application (2020-2025)
5.2.2 Global COPD and Asthma Drug Devices Revenue by Application (2026-2031)
5.2.3 Global COPD and Asthma Drug Devices Revenue Market Share by Application (2020-2031)
5.3 Global COPD and Asthma Drug Devices Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Novartis International AG
6.1.1 Novartis International AG Company Information
6.1.2 Novartis International AG Description and Business Overview
6.1.3 Novartis International AG COPD and Asthma Drug Devices Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Novartis International AG COPD and Asthma Drug Devices Product Portfolio
6.1.5 Novartis International AG Recent Developments/Updates
6.2 Merck
6.2.1 Merck Company Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck COPD and Asthma Drug Devices Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Merck COPD and Asthma Drug Devices Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 AstraZeneca
6.3.1 AstraZeneca Company Information
6.3.2 AstraZeneca Description and Business Overview
6.3.3 AstraZeneca COPD and Asthma Drug Devices Sales, Revenue and Gross Margin (2020-2025)
6.3.4 AstraZeneca COPD and Asthma Drug Devices Product Portfolio
6.3.5 AstraZeneca Recent Developments/Updates
6.4 GlaxoSmithKline
6.4.1 GlaxoSmithKline Company Information
6.4.2 GlaxoSmithKline Description and Business Overview
6.4.3 GlaxoSmithKline COPD and Asthma Drug Devices Sales, Revenue and Gross Margin (2020-2025)
6.4.4 GlaxoSmithKline COPD and Asthma Drug Devices Product Portfolio
6.4.5 GlaxoSmithKline Recent Developments/Updates
6.5 3M Healthcare
6.5.1 3M Healthcare Company Information
6.5.2 3M Healthcare Description and Business Overview
6.5.3 3M Healthcare COPD and Asthma Drug Devices Sales, Revenue and Gross Margin (2020-2025)
6.5.4 3M Healthcare COPD and Asthma Drug Devices Product Portfolio
6.5.5 3M Healthcare Recent Developments/Updates
6.6 GF Health Products, Inc
6.6.1 GF Health Products, Inc Company Information
6.6.2 GF Health Products, Inc Description and Business Overview
6.6.3 GF Health Products, Inc COPD and Asthma Drug Devices Sales, Revenue and Gross Margin (2020-2025)
6.6.4 GF Health Products, Inc COPD and Asthma Drug Devices Product Portfolio
6.6.5 GF Health Products, Inc Recent Developments/Updates
6.7 Sunovion Pharmaceuticals Inc.
6.7.1 Sunovion Pharmaceuticals Inc. Company Information
6.7.2 Sunovion Pharmaceuticals Inc. Description and Business Overview
6.7.3 Sunovion Pharmaceuticals Inc. COPD and Asthma Drug Devices Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Sunovion Pharmaceuticals Inc. COPD and Asthma Drug Devices Product Portfolio
6.7.5 Sunovion Pharmaceuticals Inc. Recent Developments/Updates
6.8 Smith Medicals, Inc.
6.8.1 Smith Medicals, Inc. Company Information
6.8.2 Smith Medicals, Inc. Description and Business Overview
6.8.3 Smith Medicals, Inc. COPD and Asthma Drug Devices Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Smith Medicals, Inc. COPD and Asthma Drug Devices Product Portfolio
6.8.5 Smith Medicals, Inc. Recent Developments/Updates
6.9 Baxter International
6.9.1 Baxter International Company Information
6.9.2 Baxter International Description and Business Overview
6.9.3 Baxter International COPD and Asthma Drug Devices Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Baxter International COPD and Asthma Drug Devices Product Portfolio
6.9.5 Baxter International Recent Developments/Updates
6.10 Koninklijke Philips N.V.
6.10.1 Koninklijke Philips N.V. Company Information
6.10.2 Koninklijke Philips N.V. Description and Business Overview
6.10.3 Koninklijke Philips N.V. COPD and Asthma Drug Devices Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Koninklijke Philips N.V. COPD and Asthma Drug Devices Product Portfolio
6.10.5 Koninklijke Philips N.V. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 COPD and Asthma Drug Devices Industry Chain Analysis
7.2 COPD and Asthma Drug Devices Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 COPD and Asthma Drug Devices Production Mode & Process Analysis
7.4 COPD and Asthma Drug Devices Sales and Marketing
7.4.1 COPD and Asthma Drug Devices Sales Channels
7.4.2 COPD and Asthma Drug Devices Distributors
7.5 COPD and Asthma Drug Devices Customer Analysis
8 COPD and Asthma Drug Devices Market Dynamics
8.1 COPD and Asthma Drug Devices Industry Trends
8.2 COPD and Asthma Drug Devices Market Drivers
8.3 COPD and Asthma Drug Devices Market Challenges
8.4 COPD and Asthma Drug Devices Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Novartis International AG
Merck
Astrazeneca plc
GlaxoSmithKline PLC
3M Healthcare
GF Health Products, Inc
Sunovion Pharmaceuticals Inc
Smith Medicals, Inc.
Baxter International
Koninklijke Philips N V
List of Tables
 Table 1. Global COPD and Asthma Drug Devices Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global COPD and Asthma Drug Devices Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global COPD and Asthma Drug Devices Market Competitive Situation by Manufacturers in 2024
 Table 4. Global COPD and Asthma Drug Devices Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global COPD and Asthma Drug Devices Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global COPD and Asthma Drug Devices Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global COPD and Asthma Drug Devices Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market COPD and Asthma Drug Devices Average Price (USD/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of COPD and Asthma Drug Devices, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of COPD and Asthma Drug Devices, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of COPD and Asthma Drug Devices, Product Type & Application
 Table 12. Global Key Manufacturers of COPD and Asthma Drug Devices, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global COPD and Asthma Drug Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in COPD and Asthma Drug Devices as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global COPD and Asthma Drug Devices Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global COPD and Asthma Drug Devices Sales by Region (2020-2025) & (K Units)
 Table 18. Global COPD and Asthma Drug Devices Sales Market Share by Region (2020-2025)
 Table 19. Global COPD and Asthma Drug Devices Sales by Region (2026-2031) & (K Units)
 Table 20. Global COPD and Asthma Drug Devices Sales Market Share by Region (2026-2031)
 Table 21. Global COPD and Asthma Drug Devices Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global COPD and Asthma Drug Devices Revenue Market Share by Region (2020-2025)
 Table 23. Global COPD and Asthma Drug Devices Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global COPD and Asthma Drug Devices Revenue Market Share by Region (2026-2031)
 Table 25. North America COPD and Asthma Drug Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America COPD and Asthma Drug Devices Sales by Country (2020-2025) & (K Units)
 Table 27. North America COPD and Asthma Drug Devices Sales by Country (2026-2031) & (K Units)
 Table 28. North America COPD and Asthma Drug Devices Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America COPD and Asthma Drug Devices Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe COPD and Asthma Drug Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe COPD and Asthma Drug Devices Sales by Country (2020-2025) & (K Units)
 Table 32. Europe COPD and Asthma Drug Devices Sales by Country (2026-2031) & (K Units)
 Table 33. Europe COPD and Asthma Drug Devices Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe COPD and Asthma Drug Devices Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific COPD and Asthma Drug Devices Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific COPD and Asthma Drug Devices Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific COPD and Asthma Drug Devices Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific COPD and Asthma Drug Devices Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific COPD and Asthma Drug Devices Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America COPD and Asthma Drug Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America COPD and Asthma Drug Devices Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America COPD and Asthma Drug Devices Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America COPD and Asthma Drug Devices Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America COPD and Asthma Drug Devices Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa COPD and Asthma Drug Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa COPD and Asthma Drug Devices Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa COPD and Asthma Drug Devices Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa COPD and Asthma Drug Devices Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa COPD and Asthma Drug Devices Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global COPD and Asthma Drug Devices Sales (K Units) by Type (2020-2025)
 Table 51. Global COPD and Asthma Drug Devices Sales (K Units) by Type (2026-2031)
 Table 52. Global COPD and Asthma Drug Devices Sales Market Share by Type (2020-2025)
 Table 53. Global COPD and Asthma Drug Devices Sales Market Share by Type (2026-2031)
 Table 54. Global COPD and Asthma Drug Devices Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global COPD and Asthma Drug Devices Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global COPD and Asthma Drug Devices Revenue Market Share by Type (2020-2025)
 Table 57. Global COPD and Asthma Drug Devices Revenue Market Share by Type (2026-2031)
 Table 58. Global COPD and Asthma Drug Devices Price (USD/Unit) by Type (2020-2025)
 Table 59. Global COPD and Asthma Drug Devices Price (USD/Unit) by Type (2026-2031)
 Table 60. Global COPD and Asthma Drug Devices Sales (K Units) by Application (2020-2025)
 Table 61. Global COPD and Asthma Drug Devices Sales (K Units) by Application (2026-2031)
 Table 62. Global COPD and Asthma Drug Devices Sales Market Share by Application (2020-2025)
 Table 63. Global COPD and Asthma Drug Devices Sales Market Share by Application (2026-2031)
 Table 64. Global COPD and Asthma Drug Devices Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global COPD and Asthma Drug Devices Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global COPD and Asthma Drug Devices Revenue Market Share by Application (2020-2025)
 Table 67. Global COPD and Asthma Drug Devices Revenue Market Share by Application (2026-2031)
 Table 68. Global COPD and Asthma Drug Devices Price (USD/Unit) by Application (2020-2025)
 Table 69. Global COPD and Asthma Drug Devices Price (USD/Unit) by Application (2026-2031)
 Table 70. Novartis International AG Company Information
 Table 71. Novartis International AG Description and Business Overview
 Table 72. Novartis International AG COPD and Asthma Drug Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 73. Novartis International AG COPD and Asthma Drug Devices Product
 Table 74. Novartis International AG Recent Developments/Updates
 Table 75. Merck Company Information
 Table 76. Merck Description and Business Overview
 Table 77. Merck COPD and Asthma Drug Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 78. Merck COPD and Asthma Drug Devices Product
 Table 79. Merck Recent Developments/Updates
 Table 80. AstraZeneca Company Information
 Table 81. AstraZeneca Description and Business Overview
 Table 82. AstraZeneca COPD and Asthma Drug Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 83. AstraZeneca COPD and Asthma Drug Devices Product
 Table 84. AstraZeneca Recent Developments/Updates
 Table 85. GlaxoSmithKline Company Information
 Table 86. GlaxoSmithKline Description and Business Overview
 Table 87. GlaxoSmithKline COPD and Asthma Drug Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. GlaxoSmithKline COPD and Asthma Drug Devices Product
 Table 89. GlaxoSmithKline Recent Developments/Updates
 Table 90. 3M Healthcare Company Information
 Table 91. 3M Healthcare Description and Business Overview
 Table 92. 3M Healthcare COPD and Asthma Drug Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 93. 3M Healthcare COPD and Asthma Drug Devices Product
 Table 94. 3M Healthcare Recent Developments/Updates
 Table 95. GF Health Products, Inc Company Information
 Table 96. GF Health Products, Inc Description and Business Overview
 Table 97. GF Health Products, Inc COPD and Asthma Drug Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 98. GF Health Products, Inc COPD and Asthma Drug Devices Product
 Table 99. GF Health Products, Inc Recent Developments/Updates
 Table 100. Sunovion Pharmaceuticals Inc. Company Information
 Table 101. Sunovion Pharmaceuticals Inc. Description and Business Overview
 Table 102. Sunovion Pharmaceuticals Inc. COPD and Asthma Drug Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 103. Sunovion Pharmaceuticals Inc. COPD and Asthma Drug Devices Product
 Table 104. Sunovion Pharmaceuticals Inc. Recent Developments/Updates
 Table 105. Smith Medicals, Inc. Company Information
 Table 106. Smith Medicals, Inc. Description and Business Overview
 Table 107. Smith Medicals, Inc. COPD and Asthma Drug Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 108. Smith Medicals, Inc. COPD and Asthma Drug Devices Product
 Table 109. Smith Medicals, Inc. Recent Developments/Updates
 Table 110. Baxter International Company Information
 Table 111. Baxter International Description and Business Overview
 Table 112. Baxter International COPD and Asthma Drug Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 113. Baxter International COPD and Asthma Drug Devices Product
 Table 114. Baxter International Recent Developments/Updates
 Table 115. Koninklijke Philips N.V. Company Information
 Table 116. Koninklijke Philips N.V. Description and Business Overview
 Table 117. Koninklijke Philips N.V. COPD and Asthma Drug Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 118. Koninklijke Philips N.V. COPD and Asthma Drug Devices Product
 Table 119. Koninklijke Philips N.V. Recent Developments/Updates
 Table 120. Key Raw Materials Lists
 Table 121. Raw Materials Key Suppliers Lists
 Table 122. COPD and Asthma Drug Devices Distributors List
 Table 123. COPD and Asthma Drug Devices Customers List
 Table 124. COPD and Asthma Drug Devices Market Trends
 Table 125. COPD and Asthma Drug Devices Market Drivers
 Table 126. COPD and Asthma Drug Devices Market Challenges
 Table 127. COPD and Asthma Drug Devices Market Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources
 Table 131. Authors List of This Report


List of Figures
 Figure 1. Product Picture of COPD and Asthma Drug Devices
 Figure 2. Global COPD and Asthma Drug Devices Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global COPD and Asthma Drug Devices Market Share by Type: 2024 & 2031
 Figure 4. COPD & Asthma Inhaler Product Picture
 Figure 5. COPD & Asthma Nebulizer Product Picture
 Figure 6. Global COPD and Asthma Drug Devices Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global COPD and Asthma Drug Devices Market Share by Application: 2024 & 2031
 Figure 8. Hospitals
 Figure 9. Clinics
 Figure 10. Others
 Figure 11. Global COPD and Asthma Drug Devices Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global COPD and Asthma Drug Devices Market Size (2020-2031) & (US$ Million)
 Figure 13. Global COPD and Asthma Drug Devices Sales (2020-2031) & (K Units)
 Figure 14. Global COPD and Asthma Drug Devices Average Price (USD/Unit) & (2020-2031)
 Figure 15. COPD and Asthma Drug Devices Report Years Considered
 Figure 16. COPD and Asthma Drug Devices Sales Share by Manufacturers in 2024
 Figure 17. Global COPD and Asthma Drug Devices Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest COPD and Asthma Drug Devices Players: Market Share by Revenue in COPD and Asthma Drug Devices in 2024
 Figure 19. COPD and Asthma Drug Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global COPD and Asthma Drug Devices Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America COPD and Asthma Drug Devices Sales Market Share by Country (2020-2031)
 Figure 22. North America COPD and Asthma Drug Devices Revenue Market Share by Country (2020-2031)
 Figure 23. U.S. COPD and Asthma Drug Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada COPD and Asthma Drug Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe COPD and Asthma Drug Devices Sales Market Share by Country (2020-2031)
 Figure 26. Europe COPD and Asthma Drug Devices Revenue Market Share by Country (2020-2031)
 Figure 27. Germany COPD and Asthma Drug Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France COPD and Asthma Drug Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. COPD and Asthma Drug Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy COPD and Asthma Drug Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia COPD and Asthma Drug Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific COPD and Asthma Drug Devices Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific COPD and Asthma Drug Devices Revenue Market Share by Region (2020-2031)
 Figure 34. China COPD and Asthma Drug Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan COPD and Asthma Drug Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea COPD and Asthma Drug Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India COPD and Asthma Drug Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia COPD and Asthma Drug Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Taiwan COPD and Asthma Drug Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Indonesia COPD and Asthma Drug Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Thailand COPD and Asthma Drug Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Malaysia COPD and Asthma Drug Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Philippines COPD and Asthma Drug Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America COPD and Asthma Drug Devices Sales Market Share by Country (2020-2031)
 Figure 45. Latin America COPD and Asthma Drug Devices Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico COPD and Asthma Drug Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil COPD and Asthma Drug Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina COPD and Asthma Drug Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa COPD and Asthma Drug Devices Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa COPD and Asthma Drug Devices Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey COPD and Asthma Drug Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia COPD and Asthma Drug Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. U.A.E COPD and Asthma Drug Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of COPD and Asthma Drug Devices by Type (2020-2031)
 Figure 55. Global Revenue Market Share of COPD and Asthma Drug Devices by Type (2020-2031)
 Figure 56. Global COPD and Asthma Drug Devices Price (USD/Unit) by Type (2020-2031)
 Figure 57. Global Sales Market Share of COPD and Asthma Drug Devices by Application (2020-2031)
 Figure 58. Global Revenue Market Share of COPD and Asthma Drug Devices by Application (2020-2031)
 Figure 59. Global COPD and Asthma Drug Devices Price (USD/Unit) by Application (2020-2031)
 Figure 60. COPD and Asthma Drug Devices Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

Dry Powder Inhaler Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Dry Powder Inhalation Device Market Research Report 2024
Global Adult Dry Powder Inhalers Market Research Report 2024
Global Multi Dose Dry Powder Inhaler Device Market Research Report 2025
Global Dry Powder Inhalation Medication Market Research Report 2024
Global Single Dose Dry Powder Inhaler Device Market Research Report 2025
Global DPI Capsules Packaging Market Research Report 2025
Global Dry Powder Inhalation Capsules Market Research Report 2024
Global Children Dry Powder Inhalers Market Research Report 2024
Global Inhaler Devices for Respiratory Medicines Market Research Report 2024
Global Inhalation Drug Delivery Devices Market Research Report 2024
Global Inhaler Devices Market Insights Forecast to 2030
Global COPD and Asthma Devices Market Research Report 2024
Global Breath actuated Inhaler Market Research Report 2025
Global COPD Inhaler Market Research Report 2025
Global Asthma and COPD Devices Market Insights Forecast to 2030
Global Corticosteroids Inhalation Formulation Market Research Report 2024
Air Inhaler Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Asthma Inhalation Formulation Market Research Report 2024
Global Mannitol DPI Market Research Report 2024

RELATED REPORTS

Global Inhaled Treatment for Asthma and COPD Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19Y19888
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Global Oxygen Inhaler Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-11D3386
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Global Chronic Obstructive Pulmonary Disorder (COPD) Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-26D2937
Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global Bronchiectasis Treatment Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-18E6080
Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions